Chargement en cours...
Denosumab and Teriparatide Transitions in Postmenopausal Osteoporosis (The DATA-Switch Study): a Randomised Controlled Trial
BACKGROUND: Unlike most chronic diseases, approved osteoporosis treatments are generally limited to a single drug at a fixed dose and frequency. Nonetheless, no approved therapy is able to restore skeletal integrity in most osteoporotic patients and the long-term use of most osteoporosis drugs remai...
Enregistré dans:
Publié dans: | Lancet |
---|---|
Auteurs principaux: | , , , , , , |
Format: | Artigo |
Langue: | Inglês |
Publié: |
2015
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4620731/ https://ncbi.nlm.nih.gov/pubmed/26144908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(15)61120-5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|